Keywords: gsk, decide, soon, exelixis, drug, option, notified
GSK to decide soon on Exelixis drug option
Article | 11 August 2008
Exelixis has notified partner GlaxoSmithKline that it has achieved proof-of-concept for XL184 under an October 2002 collaboration with the UK drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
